NEW HAVEN - The chairman of the Hospital of Saint Raphael's Department of Surgery has been named president of a national group of surgeons specializing in disorders of the liver, pancreas and bile duct.Dr. W. Scott Helton was elected by members of the American Hepato-Pancreato-Biliary Association, the hospital said.
Helton is slated to preside over the next AHPBA annual meeting in Argentina in April 2010.
Helton is slated to preside over the next AHPBA annual meeting in Argentina in April 2010.
“I am proud to say that the Americas group is the strongest and most influential of all the world’s regional chapters,” Helton said in a statement.
The AHPBA includes nearly 700 surgeons, hepatologists, gastroenterologists and members of other related disciplines from North, South and Central America.
Helton, a resident of Madison, joined the Hospital of Saint Raphael as chairman of the Department of Surgery in fall 2006, bringing with him years of experience in research, education and clinical expertise in the treatment of liver, pancreatic and hepatobiliary disorders, the statement said.
Helton previously was a professor and chief of general surgery at the University of Illinois at Chicago. He earned his undergraduate degree from the University of California, Berkeley, and graduated from the University of California, Irvine, Medical School. Helton also completed surgical training at the University of Washington and fellowship training at Harvard University and the University of Toronto.
Helton has helped expand Saint Raphael’s hepatobiliary program to include a full spectrum of diagnostic and therapeutic options for patients with primary or metastatic liver tumors and tumors of the gallbladder and bile duct. Treatment at the hospital currently includes advanced technologies such as minimally invasive surgical resection, CyberKnife radiosurgery, radiofrequency ablation, microwave ablation and angiographic delivery of chemotherapy particles.
In May 2008, Helton was the first in the country to perform microwave tissue ablation using the Acculis high-powered microwave system to treat a non-resectable liver tumor, the statement said. Saint Raphael’s was one of the first six hospitals in the United States to use the ground-breaking technology.
Helton, a resident of Madison, joined the Hospital of Saint Raphael as chairman of the Department of Surgery in fall 2006, bringing with him years of experience in research, education and clinical expertise in the treatment of liver, pancreatic and hepatobiliary disorders, the statement said.
Helton previously was a professor and chief of general surgery at the University of Illinois at Chicago. He earned his undergraduate degree from the University of California, Berkeley, and graduated from the University of California, Irvine, Medical School. Helton also completed surgical training at the University of Washington and fellowship training at Harvard University and the University of Toronto.
Helton has helped expand Saint Raphael’s hepatobiliary program to include a full spectrum of diagnostic and therapeutic options for patients with primary or metastatic liver tumors and tumors of the gallbladder and bile duct. Treatment at the hospital currently includes advanced technologies such as minimally invasive surgical resection, CyberKnife radiosurgery, radiofrequency ablation, microwave ablation and angiographic delivery of chemotherapy particles.
In May 2008, Helton was the first in the country to perform microwave tissue ablation using the Acculis high-powered microwave system to treat a non-resectable liver tumor, the statement said. Saint Raphael’s was one of the first six hospitals in the United States to use the ground-breaking technology.
No comments:
Post a Comment